Please cite:
Dimitra Karagkouni, Maria D. Paraskevopoulou, Serafeim Chatzopoulos, Ioannis S. Vlachos, Spyros Tastsoglou, Ilias Kanellos, Dimitris Papadimitriou, Ioannis Kavakiotis, Sofia Maniou, Giorgos Skoufos, Thanasis Vergoulis, Theodore Dalamagas, Artemis G. Hatzigeorgiou; DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA–gene interactions, Nucleic Acids Research, gkx1141, https://doi.org/10.1093/nar/gkx1141
Bulk download:
We have updated the bulk download module, which simplifies the download process! Please find the new online form by following this link

hsa-miR-99b-3p


Loading... Please wait, this might take a few seconds...



Filters
Clear all
Interactions: 232, Experiments: (low: , high: , unknown: ) Cell lines: , Tissues: , Publications:
Gene name miRNA name Experiments
throughput
Publications Cell lines Tissues Pred. Score
C15orf48 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Kameswaran V et al. 2014 IP Pancreas BETA Cells N/A N/A
Location Method Result Regulation Validation Type Source
chr15:45430781-45430804 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GREM1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HS5 N/A N/A
Location Method Result Regulation Validation Type Source
chr15:32733443-32733471 HITS-CLIP POSITIVE DIRECT TarBase 7.0
COQ7 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr16:19077314-19077336 HITS-CLIP POSITIVE DIRECT TarBase 7.0
BRD3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.564
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr9:134030445-134030472 HITS-CLIP POSITIVE DIRECT TarBase 7.0
UBB hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: arsenite
Location Method Result Regulation Validation Type Source
chr17:16381096-16381124 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SOCS6 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr18:70325906-70325933 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ZNF562 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Eva Gottwein et al. 2011 IP Pleura BC1 N/A N/A
Location Method Result Regulation Validation Type Source
chr19:9651191-9651218 PAR-CLIP POSITIVE DIRECT TarBase 7.0
SPSB1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.484
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:9368939-9368956 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ORMDL3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:39922377-39922403 HITS-CLIP POSITIVE DIRECT TarBase 7.0
ALG14 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr1:95064977-95065005 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KDM2A hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr11:67256321-67256341 HITS-CLIP POSITIVE DIRECT TarBase 7.0
SMARCC1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.487
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:47586769-47586790 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EIF1AX hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.559
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment:hippuristanol
Location Method Result Regulation Validation Type Source
chrX:20132192-20132211 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GOLIM4 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.536
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Xue Y et al. 2013 IP Cervix HELA N/A Hela cells were treated with control shRNA.
Location Method Result Regulation Validation Type Source
chr3:168010082-168010098 HITS-CLIP POSITIVE DIRECT TarBase 7.0
CTDSP2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.605
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Balakrishnan I et al. 2014 IP Bone Marrow HMSC N/A N/A
Location Method Result Regulation Validation Type Source
chr12:57823464-57823487 HITS-CLIP POSITIVE DIRECT TarBase 7.0
MRPL48 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr11:73864406-73864428 HITS-CLIP POSITIVE DIRECT TarBase 7.0
TGIF1 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Pillai MM et al. 2014 IP Mammary Gland MDAMB231 N/A N/A
Location Method Result Regulation Validation Type Source
chr18:3457897-3457919 HITS-CLIP POSITIVE DIRECT TarBase 7.0
GRB2 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr17:75320429-75320457 HITS-CLIP POSITIVE DIRECT TarBase 7.0
KLHL11 hsa-miR-99b-3p low: 0 high: 1 1 1 1 -
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A treatment: emetine
Location Method Result Regulation Validation Type Source
chr17:41854091-41854114 HITS-CLIP POSITIVE DIRECT TarBase 7.0
EDC3 hsa-miR-99b-3p low: 0 high: 1 1 1 1 0.483
High-throughput experiments (1 positive, 0 negative)
Publication Methods Tissue Cell line Tested cell line Exp. condition
Karginov FV et al. 2013 IP Kidney 293S N/A no treatment (control)
Location Method Result Regulation Validation Type Source
chr15:74632216-74632242 HITS-CLIP POSITIVE DIRECT TarBase 7.0